We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Abbott Diagnostics

Download Mobile App


ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

Global Blood Gas Analyzers Market to Surpass USD 940 Million by 2026

By LabMedica International staff writers
Posted on 22 Jun 2019
Print article
Image: The global blood gas analyzers market is projected to surpass USD 940 million by 2026 (Photo courtesy of iStock).
Image: The global blood gas analyzers market is projected to surpass USD 940 million by 2026 (Photo courtesy of iStock).
The global blood gas analyzers market was valued at USD 594.6 million in 2017 and is projected to grow at a CAGR of 5.5% over the forecast period (2018 – 2026) to surpass USD 940 million by 2026. The market growth is expected to be driven by the increasing global geriatric population across that is highly susceptible to various chronic diseases, aided further by increasing patients being treated in ICUs and emergency departments.

These are the latest findings of Coherent Market Insights (Seattle, WA, USA), a market research and consulting firm.

However, the high possibility of infections transmitted through blood gas analyzers that are affected by patient-acquired infections such as blood-borne pathogens during testing procedures is likely to hamper the market growth. Additionally, blood gas analyzers are difficult to use and require trained personnel. Moreover, the collection of arterial blood is more difficult than venous or capillary blood sample and can be more painful to the patient or even dangerous in case incorrect procedure is followed. All these factors are expected to negatively impact the growth of the global blood gas analyzers market.

The market players are focusing on developing cost-effective, easy-to-use blood gas analyzers that deliver reliable and fast results. They are also focusing on developing portable blood gas analyzers in order to increase the usability and comfort of the devices.

Geographically, the North American blood gas analyzers market is expected to generate significant revenue during the forecast period, driven by the rising lifestyle-induced diseases and high emergency department visits. The blood gas analyzers market in Asia-Pacific is expected to register the highest growth during the forecast period due to the region’s increasing patient population.

Related Links:
Coherent Market Insights

Print article



view channel
Image: An enzyme-linked immunosorbent assay for mannose-binding lectin found that this molecule is associated with coagulopathy in severe COVID-19 patients (Photo courtesy of Getty Images).

Mannose-Binding Lectin Associated with Coagulopathy in Severe COVID-19

The ongoing COVID-19 pandemic has caused significant morbidity and mortality worldwide, as well as profound effects on society. COVID-19 patients have an increased risk of thromboembolic (TE) complications,... Read more
Copyright © 2000-2020 Globetech Media. All rights reserved.